BAT

This brand name is authorized in United States.

Active ingredients

The drug BAT contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Botulinum antitoxin UNII `LE3J6I6DXP` - EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2
	Read more about Botulinum antitoxin
`2`	Botulinum antitoxin UNII `VSK09VP4HL` - EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2
	Read more about Botulinum antitoxin
`3`	Botulinum antitoxin UNII `X5I2P7E9TY` - EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2
	Read more about Botulinum antitoxin
`4`	Botulinum antitoxin UNII `30Y9N0SEBE` - EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2
	Read more about Botulinum antitoxin
`5`	Botulinum antitoxin UNII `T95649SUV7` - EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB2
	Read more about Botulinum antitoxin
`6`	Botulinum antitoxin UNII `RJN8G983LQ` - EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB2
	Read more about Botulinum antitoxin
`7`	Botulinum antitoxin UNII `943578J0XG` - EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2
	Read more about Botulinum antitoxin

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	60492-0075

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.